IMM-101 in the news: Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy.

Journal: Cancer Immunology, Immunotherapy

Author[s]: Daniel W. Fowler, John Copier, Natalie Wilson, Angus G. Dalgleish, Mark D. Bodman-Smith

This work was in collaboration with St George's Hospital, London

DOI: 10.1007/s00262-011-1121-4

Date: 15 October 2011


Click here to view the full article